A Study on the Risk Return Evaluation of Pharmaceutical Sector Companies
A Study on the Risk Return Evaluation of Pharmaceutical Sector Companies
Tanvi Pednekar
- Mumbai SFIMAR WIN/2025
FIN-SPE
A Study on the Risk Return Evaluation of Pharmaceutical Sector Companies
WIN/2025/FIN-SPE/PR6728
FIN-SPE
A Study on the Risk Return Evaluation of Pharmaceutical Sector Companies
WIN/2025/FIN-SPE/PR6728